Mariner LLC Buys 917 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mariner LLC grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,747 shares of the company’s stock after acquiring an additional 917 shares during the quarter. Mariner LLC’s holdings in GE HealthCare Technologies were worth $6,156,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Morse Asset Management Inc bought a new stake in GE HealthCare Technologies in the third quarter worth about $613,000. Diamant Asset Management Inc. lifted its stake in shares of GE HealthCare Technologies by 4.2% during the 3rd quarter. Diamant Asset Management Inc. now owns 10,257 shares of the company’s stock worth $963,000 after acquiring an additional 410 shares during the last quarter. World Investment Advisors LLC boosted its holdings in GE HealthCare Technologies by 44.5% during the 3rd quarter. World Investment Advisors LLC now owns 4,716 shares of the company’s stock valued at $443,000 after acquiring an additional 1,453 shares during the period. Wilmington Savings Fund Society FSB grew its position in GE HealthCare Technologies by 150.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company’s stock valued at $1,058,000 after acquiring an additional 6,770 shares during the last quarter. Finally, Tidal Investments LLC lifted its position in shares of GE HealthCare Technologies by 32.5% during the third quarter. Tidal Investments LLC now owns 23,715 shares of the company’s stock worth $2,226,000 after purchasing an additional 5,819 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $62.37 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The firm has a market cap of $28.56 billion, a price-to-earnings ratio of 14.40, a PEG ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a 50-day simple moving average of $79.26 and a two-hundred day simple moving average of $83.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.23%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of research analyst reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the stock a “buy” rating in a research report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $97.27.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.